BRIEF-Astrazeneca Pharma India Enters Distribution Agreement With Abbott Healthcare

  • Reuters
  • Stock Market News
BRIEF-Astrazeneca Pharma India Enters Distribution Agreement With Abbott Healthcare
Credit: © Reuters.

Dec 7 (Reuters) - Astrazeneca (LON: AZN ) Pharma India Ltd ASTR.NS :

* SAYS ENTERED INTO A DISTRIBUTION AGREEMENT FOR DISTRIBUTION OF DAPAGLIFLOZIN

* SAYS UNDER AGREEMENT, ABBOTT WILL PROMOTE AND DISTRIBUTE DAPAGLIFLOZIN UNDER BRAND NAME GLEDEPA

* ABBOTT WILL ALSO GAIN RIGHTS TO PROMOTE, DISTRIBUTE COMBINATION OF DAPAGLIFLOZIN WITH METFORMIN UNDER BRAND NAME GLEDEPA MET

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles